Informing on science news in the world

Provided by AGP

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on February 23, 2026

UNC Nutrition Research Institute Explores Precision Nutrition Approach in Autism Study
Enitech Marks 13-Year Milestone, Reinforcing Role in Structured Cabling for Restaurants, Including 6 Michelin-Recommended Locations
Supernus Pharmaceuticals to Participate in March Investor Conferences
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
Mstone Partners Healthcare Highlights Polaryx Therapeutics’ Latest Preclinical Data Shared at WORLDSymposium™ 2026
BlackRock® Canada Announces Final February Cash Distributions for the iShares® Premium Money Market ETF
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Palvella Therapeutics to Host Conference Call to Discuss Topline Results from Phase 3 SELVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) in Microcystic Lymphatic Malformations 
Calian Appoints Will Majic as Acting Chief Financial Officer
Smith+Nephew signs distribution agreement with SI-BONE
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Silo Pharma Announces Share Buyback Program
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution
EverQuote Announces Fourth Quarter and Full Year 2025 Financial Results
Sana Biotechnology to Present at March 2026 Investor Conferences
ROC Announces Closing of Upsized Initial Public Offering
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates

Share us

on your social networks:

Sign up for:

Science Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.